S.-T. Bong, L. N.-S. Law, and J. W.-F. Law, “A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM)”, Prog Micobes Mol Biol, vol. 2, no. 1, May 2019.